State of Alaska Department of Revenue Buys 4,197 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

State of Alaska Department of Revenue raised its stake in shares of UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 3.0% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 144,947 shares of the healthcare conglomerate’s stock after buying an additional 4,197 shares during the period. UnitedHealth Group accounts for approximately 0.9% of State of Alaska Department of Revenue’s portfolio, making the stock its 11th biggest holding. State of Alaska Department of Revenue’s holdings in UnitedHealth Group were worth $74,447,000 as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. Advocacy Wealth Management Services LLC increased its stake in shares of UnitedHealth Group by 75.8% in the first quarter. Advocacy Wealth Management Services LLC now owns 58 shares of the healthcare conglomerate’s stock worth $30,000 after purchasing an additional 25 shares during the period. Cascade Investment Advisors Inc. increased its stake in shares of UnitedHealth Group by 100.0% in the first quarter. Cascade Investment Advisors Inc. now owns 60 shares of the healthcare conglomerate’s stock worth $31,000 after purchasing an additional 30 shares during the period. Rise Advisors LLC bought a new position in shares of UnitedHealth Group in the fourth quarter worth about $38,000. Evolution Advisers Inc. bought a new position in shares of UnitedHealth Group in the first quarter worth about $38,000. Finally, Cordant Inc. bought a new position in shares of UnitedHealth Group in the first quarter worth about $45,000. 87.25% of the stock is currently owned by institutional investors.

UnitedHealth Group Stock Performance

UNH stock opened at $521.02 on Monday. The company has a debt-to-equity ratio of 0.60, a current ratio of 0.77 and a quick ratio of 0.77. The company has a 50 day moving average price of $529.29 and a 200 day moving average price of $511.81. UnitedHealth Group Incorporated has a fifty-two week low of $383.12 and a fifty-two week high of $553.29. The stock has a market capitalization of $487.35 billion, a PE ratio of 27.21, a price-to-earnings-growth ratio of 1.63 and a beta of 0.76.

UnitedHealth Group (NYSE:UNHGet Rating) last posted its quarterly earnings data on Friday, July 15th. The healthcare conglomerate reported $5.57 earnings per share for the quarter, topping the consensus estimate of $5.24 by $0.33. UnitedHealth Group had a net margin of 5.95% and a return on equity of 25.45%. The firm had revenue of $80.33 billion during the quarter, compared to analysts’ expectations of $79.68 billion. During the same quarter in the previous year, the company posted $4.70 EPS. UnitedHealth Group’s revenue was up 12.6% on a year-over-year basis. Analysts forecast that UnitedHealth Group Incorporated will post 21.85 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 20th. Shareholders of record on Monday, September 12th will be given a dividend of $1.65 per share. This represents a $6.60 annualized dividend and a dividend yield of 1.27%. The ex-dividend date is Friday, September 9th. UnitedHealth Group’s payout ratio is 34.46%.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,273 shares of the company’s stock in a transaction on Thursday, June 23rd. The shares were sold at an average price of $499.00, for a total transaction of $635,227.00. Following the completion of the sale, the executive vice president now owns 8,104 shares in the company, valued at approximately $4,043,896. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, EVP Erin Mcsweeney sold 1,273 shares of the company’s stock in a transaction on Thursday, June 23rd. The shares were sold at an average price of $499.00, for a total value of $635,227.00. Following the completion of the sale, the executive vice president now owns 8,104 shares in the company, valued at approximately $4,043,896. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, CEO Andrew Witty sold 11,376 shares of the company’s stock in a transaction on Monday, July 18th. The shares were sold at an average price of $527.90, for a total transaction of $6,005,390.40. Following the completion of the sale, the chief executive officer now owns 76,559 shares of the company’s stock, valued at approximately $40,415,496.10. The disclosure for this sale can be found here. In the last 90 days, insiders sold 140,324 shares of company stock worth $75,086,185. Insiders own 0.40% of the company’s stock.

Analyst Ratings Changes

UNH has been the topic of several research reports. UBS Group boosted their price target on UnitedHealth Group from $545.00 to $570.00 and gave the company a “neutral” rating in a research note on Thursday, July 21st. Mizuho boosted their price target on UnitedHealth Group from $550.00 to $600.00 and gave the company a “buy” rating in a research note on Wednesday, August 10th. Loop Capital initiated coverage on UnitedHealth Group in a research note on Thursday, June 16th. They set a “buy” rating and a $575.00 price target on the stock. Oppenheimer boosted their price target on UnitedHealth Group from $600.00 to $610.00 and gave the company an “outperform” rating in a research note on Monday, July 18th. Finally, Wells Fargo & Company decreased their price objective on UnitedHealth Group from $613.00 to $612.00 and set an “overweight” rating on the stock in a report on Wednesday, May 25th. Three investment analysts have rated the stock with a hold rating, fifteen have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat, UnitedHealth Group presently has an average rating of “Moderate Buy” and a consensus price target of $585.65.

UnitedHealth Group Company Profile

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Further Reading

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHGet Rating).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.